The Use of Continuous Treatment Versus Placebo or Intermittent Treatment Strategies in Stabilized Patients with Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials with First- and Second-Generation Antipsychotics
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Use of Continuous Treatment Versus Placebo or Intermittent Treatment Strategies in Stabilized Patients with Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials with First- and Second-Generation Antipsychotics
Authors
Keywords
Schizophrenia, Antipsychotic Medication, Continuous Treatment, Antipsychotic Treatment, Asenapine
Journal
CNS DRUGS
Volume 29, Issue 8, Pages 637-658
Publisher
Springer Nature
Online
2015-08-20
DOI
10.1007/s40263-015-0269-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Long-acting injectable antipsychotics: shall the last be first?
- (2014) Stephen M. Stahl CNS SPECTRUMS
- Treatment of early episode in patients with schizophrenia: the role of long acting antipsychotics
- (2014) S. Heres et al. EUROPEAN PSYCHIATRY
- First-Episode Psychosis and Disengagement From Treatment: A Systematic Review
- (2014) Roisin Doyle et al. PSYCHIATRIC SERVICES
- Does treatment of schizophrenia with antipsychotic medications eliminate or reduce psychosis? A 20-year multi-follow-up study
- (2014) M. Harrow et al. PSYCHOLOGICAL MEDICINE
- Antipsychotic Treatment and Mortality in Schizophrenia
- (2014) M. Torniainen et al. SCHIZOPHRENIA BULLETIN
- How study designs influence comparative effectiveness outcomes: The case of oral versus long-acting injectable antipsychotic treatments for schizophrenia
- (2014) Larry Alphs et al. SCHIZOPHRENIA RESEARCH
- A prospective comparative study of risperidone long-acting injectable for treatment-resistant schizophrenia with dopamine supersensitivity psychosis
- (2014) Hiroshi Kimura et al. SCHIZOPHRENIA RESEARCH
- Efficacy of Pharmacotherapy and Psychotherapy for Adult Psychiatric Disorders
- (2014) Maximilian Huhn et al. JAMA Psychiatry
- Impact of Early Nonadherence to Oral Antipsychotics on Clinical and Economic Outcomes Among Patients with Schizophrenia
- (2013) Steve Offord et al. ADVANCES IN THERAPY
- Relapse Duration, Treatment Intensity, and Brain Tissue Loss in Schizophrenia: A Prospective Longitudinal MRI Study
- (2013) Nancy C. Andreasen et al. AMERICAN JOURNAL OF PSYCHIATRY
- Long-acting injectable formulations of antipsychotic drugs for the treatment of schizophrenia
- (2013) Eun Ji Park et al. ARCHIVES OF PHARMACAL RESEARCH
- Guidelines for the use and management of long-acting injectable antipsychotics in serious mental illness
- (2013) Pierre Michel Llorca et al. BMC Psychiatry
- The nature of relapse in schizophrenia
- (2013) Robin Emsley et al. BMC Psychiatry
- Long-acting injectable antipsychotics in early psychosis: a literature review
- (2013) Robin Emsley et al. Early Intervention in Psychiatry
- Clinical outcomes of long-acting risperidone in recent versus long-term diagnosed Belgian schizophrenic patients: results from electronic Schizophrenia Treatment Adherence Registry (e-STAR) and Trial for the Initiation and Maintenance Of REmission in Schi
- (2013) Vincent Dubois et al. Early Intervention in Psychiatry
- Practical management of schizophrenia
- (2013) Timothy J. Lambert INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Assessing the comparative effectiveness of long-acting injectable vs. oral antipsychotic medications in the prevention of relapse provides a case study in comparative effectiveness research in psychiatry
- (2013) John M. Kane et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Monitoring Treatment and Managing Adherence in Schizophrenia
- (2013) Stephen R. Marder JOURNAL OF CLINICAL PSYCHIATRY
- Long-Acting Injectable Versus Oral Antipsychotics in Schizophrenia
- (2013) Taishiro Kishimoto et al. JOURNAL OF CLINICAL PSYCHIATRY
- Efficacy and Effectiveness of Depot Versus Oral Antipsychotics in Schizophrenia
- (2013) Noam Y. Kirson et al. JOURNAL OF CLINICAL PSYCHIATRY
- Optimal Extent of Dopamine D2 Receptor Occupancy by Antipsychotics for Treatment of Dopamine Supersensitivity Psychosis and Late-Onset Psychosis
- (2013) Masaomi Iyo et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Intermittent Drug Techniques for Schizophrenia
- (2013) S. Sampson et al. SCHIZOPHRENIA BULLETIN
- Does Long-Term Treatment of Schizophrenia With Antipsychotic Medications Facilitate Recovery?
- (2013) M. Harrow et al. SCHIZOPHRENIA BULLETIN
- Is the ongoing use of placebo in relapse-prevention clinical trials in schizophrenia justified?
- (2013) Robin Emsley et al. SCHIZOPHRENIA RESEARCH
- The neurobiology of relapse in schizophrenia
- (2013) Gary Remington et al. SCHIZOPHRENIA RESEARCH
- Risk of symptom recurrence with medication discontinuation in first-episode psychosis: A systematic review
- (2013) Robert B. Zipursky et al. SCHIZOPHRENIA RESEARCH
- Are there clinically useful predictors and early warning signs for pending relapse?
- (2013) Wolfgang Gaebel et al. SCHIZOPHRENIA RESEARCH
- Non-adherence to medication in patients with psychotic disorders: epidemiology, contributing factors and management strategies
- (2013) John M. Kane et al. World Psychiatry
- Incomplete medication adherence of chronically ill patients in German primary care
- (2013) Jakob Hüther et al. Patient Preference and Adherence
- Impact of long-acting injectable antipsychotics on medication adherence and clinical, functional, and economic outcomes of schizophrenia
- (2013) Gabriel Kaplan et al. Patient Preference and Adherence
- Systematic review of the economic aspects of nonadherence to antipsychotic medication in patients with schizophrenia
- (2013) Tatiana Dilla et al. Patient Preference and Adherence
- Long-acting injectable paliperidone palmitate versus oral paliperidone extended release: a comparative analysis from two placebo-controlled relapse prevention studies
- (2013) Michael Markowitz et al. Annals of General Psychiatry
- Recovery in Remitted First-Episode Psychosis at 7 Years of Follow-up of an Early Dose Reduction/Discontinuation or Maintenance Treatment Strategy
- (2013) Lex Wunderink et al. JAMA Psychiatry
- [No Title]
- (2012) Nev Jones BRITISH JOURNAL OF PSYCHIATRY
- [No Title]
- (2012) Shona M. Francey et al. BRITISH JOURNAL OF PSYCHIATRY
- Antipsychotics: is it time to introduce patient choice?
- (2012) Anthony P. Morrison et al. BRITISH JOURNAL OF PSYCHIATRY
- Symptom Recurrence Following Intermittent Treatment in First-Episode Schizophrenia Successfully Treated for 2 Years
- (2012) Robin Emsley et al. JOURNAL OF CLINICAL PSYCHIATRY
- Aripiprazole Intramuscular Depot as Maintenance Treatment in Patients With Schizophrenia
- (2012) John M. Kane et al. JOURNAL OF CLINICAL PSYCHIATRY
- Comparison of Treatment Response in Second-Episode Versus First-Episode Schizophrenia
- (2012) Robin Emsley et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Adherence to Antipsychotics and Cardiometabolic Medication: Association With Health Care Utilization and Costs
- (2012) Richard A. Hansen et al. PSYCHIATRIC SERVICES
- Do all schizophrenia patients need antipsychotic treatment continuously throughout their lifetime? A 20-year longitudinal study
- (2012) M. Harrow et al. PSYCHOLOGICAL MEDICINE
- Long-Acting Injectable vs Oral Antipsychotics for Relapse Prevention in Schizophrenia: A Meta-Analysis of Randomized Trials
- (2012) T. Kishimoto et al. SCHIZOPHRENIA BULLETIN
- Impact on intracortical myelination trajectory of long acting injection versus oral risperidone in first-episode schizophrenia
- (2012) George Bartzokis et al. SCHIZOPHRENIA RESEARCH
- Risk factors for relapse following treatment for first episode psychosis: A systematic review and meta-analysis of longitudinal studies
- (2012) M. Alvarez-Jimenez et al. SCHIZOPHRENIA RESEARCH
- World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 2: Update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects
- (2012) Alkomiet Hasan et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- A Nationwide Cohort Study of Oral and Depot Antipsychotics After First Hospitalization for Schizophrenia
- (2011) Jari Tiihonen et al. AMERICAN JOURNAL OF PSYCHIATRY
- Antipsychotic Medications and Brain Volume
- (2011) David A. Lewis ARCHIVES OF GENERAL PSYCHIATRY
- Long-term Antipsychotic Treatment and Brain Volumes
- (2011) Beng-Choon Ho et al. ARCHIVES OF GENERAL PSYCHIATRY
- Characteristics of subjects with schizophrenia spectrum disorder with and without antipsychotic medication – A 10-year follow-up of the Northern Finland 1966 Birth Cohort study
- (2011) J. Moilanen et al. EUROPEAN PSYCHIATRY
- A Randomized Placebo-Controlled Trial of Asenapine for the Prevention of Relapse of Schizophrenia After Long-Term Treatment
- (2011) John M. Kane et al. JOURNAL OF CLINICAL PSYCHIATRY
- Adherence Disparities in Mental Health
- (2011) Lisa Dixon et al. JOURNAL OF NERVOUS AND MENTAL DISEASE
- Evidence-based guidelines for the pharmacological treatment of schizophrenia: recommendations from the British Association for Psychopharmacology
- (2011) Thomas RE Barnes et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Long-Acting Risperidone and Oral Antipsychotics in Unstable Schizophrenia
- (2011) Robert A. Rosenheck et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long acting injection versus oral risperidone in first-episode schizophrenia: Differential impact on white matter myelination trajectory
- (2011) George Bartzokis et al. SCHIZOPHRENIA RESEARCH
- Antipsychotic treatment for schizophrenia in the maintenance phase: A systematic review of the guidelines and algorithms
- (2011) Hiroyoshi Takeuchi et al. SCHIZOPHRENIA RESEARCH
- Does long-acting injectable risperidone make a difference to the real-life treatment of schizophrenia? Results of the Cohort for the General study of Schizophrenia (CGS)
- (2011) Lamiae Grimaldi-Bensouda et al. SCHIZOPHRENIA RESEARCH
- All Roads to Schizophrenia Lead to Dopamine Supersensitivity and Elevated Dopamine D2High Receptors
- (2010) Philip Seeman CNS Neuroscience & Therapeutics
- From receptor pharmacology to improved outcomes: individualising the selection, dosing, and switching of antipsychotics
- (2010) C.U. Correll EUROPEAN PSYCHIATRY
- Risperidone long-acting therapy in stable patients with recently diagnosed schizophrenia
- (2010) Wayne Macfadden et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Antipsychotic prophylaxis is needed after remission from a first psychotic episode in schizophrenia patients: Results from an aborted randomised trial
- (2010) Geartsje Boonstra et al. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
- “Extended” Antipsychotic Dosing in the Maintenance Treatment of Schizophrenia
- (2010) Gary Remington et al. JOURNAL OF CLINICAL PSYCHIATRY
- Relapse Prevention in First-Episode Schizophrenia—Maintenance vs Intermittent Drug Treatment With Prodrome-Based Early Intervention
- (2010) Wolfgang Gaebel et al. JOURNAL OF CLINICAL PSYCHIATRY
- The heterogeneity of antipsychotic response in the treatment of schizophrenia
- (2010) M. Case et al. PSYCHOLOGICAL MEDICINE
- Schizophrenia, “Just the Facts” 5. Treatment and prevention Past, present, and future
- (2010) Rajiv Tandon et al. SCHIZOPHRENIA RESEARCH
- Clinical guideline recommendations for antipsychotic long-acting injections
- (2009) John M. Kane et al. BRITISH JOURNAL OF PSYCHIATRY
- Oral versus injectable antipsychotic treatment in early psychosis: Post hoc comparison of two studies
- (2009) Robin Emsley et al. CLINICAL THERAPEUTICS
- Are Weight Gain and Metabolic Side Effects of Atypical Antipsychotics Dose Dependent?
- (2009) Viktoria Simon et al. JOURNAL OF CLINICAL PSYCHIATRY
- The Schizophrenia Patient Outcomes Research Team (PORT): Updated Treatment Recommendations 2009
- (2009) Julie Kreyenbuhl et al. SCHIZOPHRENIA BULLETIN
- Paliperidone palmitate maintenance treatment in delaying the time-to-relapse in patients with schizophrenia: A randomized, double-blind, placebo-controlled study
- (2009) David Hough et al. SCHIZOPHRENIA RESEARCH
- Remission in patients with first-episode schizophrenia receiving assured antipsychotic medication: a study with risperidone long-acting injection
- (2008) Robin Emsley et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Effectiveness of risperidone long-acting injection in first-episode schizophrenia: In naturalistic setting
- (2008) Borah Kim et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search